id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-296187-nnv2e7gr	Mulgaonkar, Nirmitee	Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19	2020-08-18		.txt	text/plain	4966	219	50	key: cord-296187-nnv2e7gr authors: Mulgaonkar, Nirmitee; Wang, Haoqi; Mallawarachchi, Samavath; Fernando, Sandun; Martina, Byron; Ruzek, Daniel title: Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19 date: 2020-08-18 journal: bioRxiv DOI: 10.1101/2020.06.18.158196 sha: doc_id: 296187 cord_uid: nnv2e7gr The rapid geographic expansion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the infectious agent of Coronavirus Disease 2019 (COVID-19) pandemic, poses an immediate need for potent drugs. VSV-G particles cells do not carry spike proteins and thus, no significant entry inhibition occurred, suggesting that entry inhibition is likely mediated through the spike protein.	cache/cord-296187-nnv2e7gr.txt	txt/cord-296187-nnv2e7gr.txt
